This has lead to comparisons of the company to Martin Shkreli and Valeant Pharmaceuticals, given the lack of competitor products.
The Sad State of Product Design and Innovation in Healthcare
Doctor as Designer
20419
That’s just for public consumption, Shkreli used business models no different than any big pharma R+D, patent purchasing and price hiking.